New England Journal of Medicine Publishes eNRGy Trial Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer ...
Many Charlotte-area residents are familiar with some of the more notable figures in local Black history, people like Harvey Gantt, the first Black student accepted to enroll at Clemson University who ...
Global academic community unites against predatory journals, urging action to combat threats to scholarly integrity in ...
The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...
In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...
8h
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...
Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
The researchers found that imlunestrant prolonged progression-free survival (PFS) when compared to standard care in patients with ESR1 mutations, but there was no PFS benefit observed in the overall ...
13h
How do highly successful people handle some of life’s biggest obstacles? Twenty years of research points to a simple brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback